By Dorothy Ogwuru, Founder, PharmaLink Academy. 18 years in regulatory medical writing and pharmacovigilance across Schering-Plough, MSD, Amgen, Takeda, Roche, AstraZeneca, and GSK as Senior Regulatory Medical Writer. Last updated 19 May 2026.

Why doctors are an actively recruited talent pool in pharma

UK pharmaceutical industry hiring managers do not view doctor applicants as career changers. They view them as a premium candidate pool whose clinical reasoning, documentation discipline and regulatory literacy already approach the standard required of an industry medical writer.

That is the perception inside hiring teams at GSK, AstraZeneca, Roche, Pfizer, Novartis, Sanofi, Daiichi Sankyo, Novo Nordisk and the CRO tier. It is not the perception most doctors hold of themselves when they first consider the move. The gap between the two is what this guide is designed to close.

The role most doctors enter is Regulatory Medical Writer. You will write the clinical and regulatory documents that pharmaceutical sponsors submit to health authorities like the MHRA, EMA, FDA and Health Canada when seeking approval to study, market or vary a medicine. Clinical Study Reports. Module 2 summaries within the Common Technical Document. Investigator's Brochures. Regulatory responses. Briefing documents for scientific advice meetings. These are the documents that determine whether a drug reaches patients.

What a regulatory medical writer actually does, in language a doctor will recognise

If you have written a clinic letter that another clinician acted on, you have done the foundational version of this work. If you have written a case report that a journal accepted, you have done a closer version. If you have written a guideline section, an audit report or a research paper, you have done the closest version. Regulatory medical writing is what you get when those skills are formalised against the precision a health authority reviewer demands.

The day-to-day work breaks down into roughly four buckets.

The discipline is structural writing under high precision demand. Sentences mean what they say and the same sentence cannot mean two different things to two different readers. That is the standard. It is the same standard you applied to writing a clinical letter that influenced another doctor's decision, expanded across a 300-page document.

The realistic doctor to medical writer timeline

Most doctors who make this pivot do so on a 9 to 12 month timeline, working alongside their existing clinical rota until they secure the offer. The timeline accelerates if you can dedicate more hours per week and slows if your rota is heavier than average. Both extremes are common.

Salary uplift compared to NHS clinical practice

The financial comparison is rarely as straightforward as headline numbers suggest. NHS pay is supplemented by London weighting, banding, on-call enhancements, study leave allowances and pension contributions that pharmaceutical salaries replace differently. Below is the honest comparison most doctors actually see.

The non-salary factors matter more than most doctors initially realise. Industry medical writing roles are predominantly hybrid or fully remote across the UK. The unsocial-hours pattern of clinical practice disappears. Annual leave is genuinely usable. Study budgets exist, often generous. The work travels well if you choose to relocate to mainland Europe or North America later.

UK employers who hire doctors into regulatory medical writing

The pharmaceutical employer pool that actively recruits clinically-trained medical writers in the UK splits into four tiers.

The pattern across all four tiers is that UK hiring managers respond best to doctor applicants who have evidence they can already write to the regulatory standard. The evidence does not need to be inside a sponsor or CRO. It can be on a portfolio built during a structured programme. What it cannot be is absent.

Transferable skills doctors already have

Doctors arrive in the regulatory medical writing application pool with more transferable skills than almost any other clinical background. Mapping them explicitly on your CV is the single highest-leverage repositioning move you can make.

The CV translation is not invention. It is making explicit what is already implicit. Most doctors leave this implicit and lose interviews to candidates from less clinically-rich backgrounds who simply named what they had done.

The interview pattern doctors should prepare for

UK pharmaceutical hiring panels for medical writer roles use scenario-based interviewing. For doctors specifically, the interview hinges on a small number of recurring questions designed to test whether you have made the conceptual jump from clinical practice to regulated industry documentation.

• Tell me about a time you had to translate complex clinical data into a document for a non-clinical audience. Answer with a guideline you wrote, an audit report you presented, or a patient-facing communication. The hiring manager is testing your translation discipline.
• What is the difference between a Clinical Study Report and a Module 2.7 Clinical Summary? They are testing whether you have actually engaged with the document types, not just the buzzwords. Have a structured 90-second answer prepared.
• You receive a CSR draft with a discrepancy between the statistical analysis plan and the results section. What do you do? The right answer is direct contact with the biostatistician, not escalation upwards. Industry rewards problem-solvers, not problem-escalators.
• Why are you leaving clinical practice? The strongest answers do not criticise the NHS or clinical work. They describe a positive pull towards population-level impact, structured documentation work, and the kind of regulatory contribution that influences how a drug reaches every patient who needs it.
• How would you handle disagreement with a senior clinician about the wording of a regulatory document? The answer demonstrates that you can hold the regulatory standard whilst respecting clinical judgement. Industry writing requires both.

For a deeper guide to the questions UK pharma hiring panels actually ask, see Pharma Interview Questions UK.

The gap our RMW programme closes for doctors

Most doctors who attempt this transition independently do the first two stages well — they learn the regulatory frameworks, and they read enough CSRs and Module 2 documents to be conversationally fluent. The gap that stalls applications is the portfolio. UK industry hiring managers will read a CV that lists ICH familiarity and skim past it. They will stop on a CV that includes a written CSR sample, a Module 2.7 draft, or an Investigator's Brochure section.

Frequently asked questions

Do I need to leave clinical practice before I apply for medical writing roles in the UK? No. The vast majority of doctors complete the transition training and submit applications alongside their clinical rota, and resign only after the offer is signed. Live programmes are typically built around evening sessions to fit clinical shifts.

Do I need a PhD or a postgraduate qualification to become a medical writer? No. UK hiring managers do not screen for PhD when reviewing applications from medical doctors. The MBBS or MBChB is the qualification they care about. A PhD is a marginal advantage in some therapy areas, particularly oncology, but is not a prerequisite.

How much of my clinical specialty matters when I apply for medical writing roles? Less than most doctors expect. Sponsors and CROs have specific therapy area teams, so an oncology background helps with oncology vacancies and a cardiology background helps with cardiovascular vacancies. But the underlying regulatory writing skillset is therapy-area agnostic. Many doctors enter on a different therapy area to their clinical background and move within industry once established.

Will I lose clinical credibility if I move to industry? This is the question doctors ask each other but rarely ask the hiring panel. The honest answer is that industry medical writing roles are well-respected within UK healthcare professional communities, but the route back to clinical practice after a long industry tenure is not straightforward if that ever becomes a consideration. Most doctors who make the move do not move back.

How much of the work is solo versus team-based? Drafting a document is solo work. Reviewing, revising and submitting it is team-based. Expect a meaningful proportion of your week to be in cross-functional meetings with biostatistics, clinical operations, regulatory affairs, safety and project management. The work is less isolated than it sounds.

Is the move reversible? Partially. You will not lose your GMC registration by working in industry, and locum work alongside an industry role is technically possible in some specialties, though many doctors find the diary control of an industry role makes occasional locum work logistically harder, not easier. Treat the move as primary, not as a hedge.